DeutschNewstral
Article
USA today on 2015-10-12 15:51
Eli Lilly ends drug development, stock plunges
Related news
Eli Lilly ends development of insulin peglisproelkharttruth.com- BEli Lilly Stock Rises as Earnings Guidance Beats Analyst Expectationsbarrons.com
- MEli Lilly ends development of BIL diabetes treatmentmarketwatch.com
- BEli Lilly Stock Falls as Sales Disappoint. Analyst Welcomes Diabetes Data.barrons.com
- MIncyte's stock surges after receiving milestone payment from Eli Lillymarketwatch.com
- DAnalysts revamp Eli Lilly stock price target on weight-loss drugsdcourier.com
- DAnalyst revamps Eli Lilly stock price target on weight loss drugdcourier.com
- BEli Lilly Earned More Than Expected. Here’s Why the Stock Is Falling Anyway.barrons.com
- BEli Lilly Stock Is Soaring. Sales Bounced Back.2 min readbarrons.com
Weight-Loss Drug Frenzy Drives Eli Lilly And Novo Nordisk Stock To Record HighsForbes- TPoint Biopharma Global stock soars on $1.4 takeover bid from Eli Lillythestreet.com
Eli Lilly changes outcome goals in Alzheimer's drug studyThe Salt Lake Tribune- FEli Lilly dives as it scraps heart drugft.com
Eli Lilly starts website to connect patients with prescriptionsstaradvertiser.com
Eli Lilly: Why Earnings Guidance Takes a Back Seatwsj.com- TEli Lilly caps insulin costs at $35 per monththehill.com
- MEli Lilly's stock tumbles after termination of heart disease drug's developmentmarketwatch.com
- BEli Lilly Stock Climbs After a Glowing Earnings Reportbarrons.com
- Is Pfizer Stock A Better Bet Compared To Eli Lilly?Forbes